LOS ANGELES, June 5, 2023 /PRNewswire/ — A federal court unsealed an order that certified a national multi-billion dollar class action against Takeda Pharmaceutical Company and Eli Lilly and Company, alleging that the companies violated the civil Racketeer Influenced and Corrupt Organizations Act (RICO) by concealing the risk of Actos and bladder cancer. The Hon. … Read more
TAMPA, Fla., May 24, 2023 /PRNewswire/ — Wisner Baum will serve as lead counsel in the upcoming trial of Jeffrey Thelen v. Somatics, LLC and Elektrika, Inc. Jury selection and opening statements begin on Wednesday, May 31, 2023, in Tampa, Florida before U.S. District Court Judge Thomas Barber. The trial is expected to last until June 9, … Read more
WILMINGTON, Del., May 17, 2023 /PRNewswire/ — Wisner Baum managing partner R. Brent Wisner will be co-lead trial counsel in the Zantac (Ranitidine) Products Liability litigation (Civil Action No. N22C-09-101 ZAN) in Delaware Superior Court. Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware Judge Vivian L. Medinilla named Wisner and three others … Read more